![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 25, 2009 12:36:40 PM
Regarding the product pricing and commercial content ;
$40.+ for a product that can do what this one does for chronic sufferers is 'chump-change'. Having had ezcema & paying the costs for 40 years, I can speak 1st-hand that $40. is 'nothing' for a product that gets the job done: Costs are even more of a burden for the more serious malady , psoriasis.
On the content: I think it gets the point across , particularly for psoriasis but I think they'd be well-advised the put an 'equal' emphasis on acne and ezcema to appeal to wider audience. Acne is very briefly mentioned and ezcema isn't mentioned at all , although (according to their PR) it works on ezcema too. To my knowledge, there are far more people suffering from acne and ezcema than psoriasis. I would also recommend that they put more emphasis on doing business by 'website' , as opposed to using the 'phone'. Many people prefer using their computers to do business and it gives AVVH a 2nd chance to sell their 'full' product-line , complete w/ more exhaustive descriptions and technical info on 'how-it-works'.
Thats just my 10cents worth anyway.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM